A Comparative study of 0.3% Topical Nifedipine Ointment vs Lateral Sphincterotomy in the Treatment of Chronic Anal Fissure
Background: Chronic anal fissure is a common anorectal condition marked by significant discomfort and morbidity. Topical chemical sphincter relaxation and surgical sphincterotomy are both recognized methods for treating this disease. This study aimed to assess the efficacy, analgesic effects, healing outcomes, and adverse effects of topical 0.3% nifedipine with lateral internal sphincterotomy in patients suffering from chronic anal fissure. Material and Methods: A randomized controlled experiment was conducted over the course of one year in a tertiary care institution. Sixty patients were divided into two groups of thirty. Group I was administered topical 0.3% nifedipine, whereas Group II had lateral internal sphincterotomy. Patients were assessed at 2, 4, 8, and 12 weeks to measure pain (VAS score), healing progression, and adverse events. Results: The healing rates of both groups improved over time; however, Group II's healing was consistently quicker and slightly more effective. At the conclusion of 12 weeks, 96.7% of patients in Group I and 100% of patients in Group II had achieved healing. The sphincterotomy cohort had significantly reduced pain scores at both 2 and 4 weeks (p < 0.05). Headaches and flushes were much more prevalent in the nifedipine cohort, but only the surgical cohort experienced mild incontinence. Conclusion: Lateral internal sphincterotomy provides rapid pain relief and rapid recovery, whereas topical nifedipine acts as an effective, non-invasive option with few reversible side effects.
Authors
- A. Zahir Hussain
- V. Sibi
- P. Karthick
Institutions
- Trichy SRM Medical College Hospital and Research Centre (IN)
Publication Details
- Journal
- International Journal of Drug Delivery Technology
- Published
- 2026-11-16
- DOI
- https://doi.org/10.25258/ijddt.16.80s.92
- Primary Topic
- Anorectal Disease Treatments and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00